(Q27313572)

English

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

phase III clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

David I. Rosenthal

object named as

David I Rosenthal

5

0 references

7

object named as

Harold Kim

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

4

object named as

Randal S Weber

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Phuc Felix Nguyen-Tan

1

object named as

Phuc Felix Nguyen-Tan

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

17

object named as

Marcie List

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

18

object named as

Quynh-Thu Le

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Maura L. Gillison

16

object named as

Maura L Gillison

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

William H. Westra

13

object named as

William H Westra

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

3

object named as

K Kian Ang

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Christine H. Chung

14

object named as

Christine H Chung

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

author name string

Qiang Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Denis Soulieres

6

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Craig Silverman

8

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Adam Raben

9

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Thomas J Galloway

10

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

André Fortin

11

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Elizabeth Gore

12

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Richard C Jordan

15

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

language of work or name

0 references

publication date

3 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

3858-3866

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

21 March 2017

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

21 March 2017

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

7 April 2017

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 September 2017

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

31 May 2018

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

31 May 2018

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 November 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4239304

28 November 2018

Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366680

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2014.55.3925

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

release_dexitt4h3zfvbktp36ynfwkdoe

1 reference

https://api.fatcat.wiki/v0/release/dexitt4h3zfvbktp36ynfwkdoe

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27313572&oldid=2265304685"